Cross-reactions between two strains of foot-and-mouth disease virus (FMDV) belonging to different serotypes (A and O) were studied with intact virus and virus subunits and antisera produced against the isolated structural proteins. Anti-VP~ type O serum showed cross-reactive neutralizing activity, in contrast to the sera raised against intact virus type O, whereas anti-VP1 type A serum only neutralized homologous virus. Anti-VP2, VPa and VP~ did not show neutralizing activity. In the enzyme-linked immunosorbent assay and radio-immunoassay anti-VP~, -VP 2 and -VP 3 sera reacted with the I2S virus subunits of both serotypes. No activity was obtained against VP 4. Competition experiments with virus subunits of virus type A and O show that anti-VP~ serum is the most typespecific. Anti-VPz serum is completely cross-reactive, while anti-VP~ serum reacted in an intermediate way. The identical reactions obtained with anti-VP2 sera and the homologous and heterologous virus subunits suggest that the exposed VP2 antigens are identical.
INTRODUCTION
It is generally accepted that intact picornaviruses have the D antigenic conformation. This conformation is responsible for induction of serotype-specific neutralizing activity and cell attachment. Degraded picornaviruses possess the C antigenic conformation, they do not induce neutralizing activity but expose internal antigens responsible for crossreactions between serotypes (Rowlands et al. I969; Forsgren, 1972; Lonberg-Holm & Yin, I973; Rueckert, 1976; Cooper et al. 1978; Smith, 1978; Rweyemamu & Pay, I979) . Picornaviruses have four structural proteins usually identified as VPI, YP2, VP 3 and VP4. They may be defined by their relative position on the virus genome, the order from 5' to 3' being: VP4, VP2, VPa, VP1 (reviewed by Sangar, I979) . Intact picornaviruses expose mainly VPI (Rueckert, 1976) , whereas, after degradation, VP2 and VP3 are also exhibited (Carthew & Martin, t974; Beneke et al. I977; Lund et al. I977; Meloen et al. I979) . Because the intact picornaviruses carry serotype-specific antigens and VP1 is the protein mainly exposed on the virion, these type-specific antigens are probably located on VPa. No information is available, however, on the presence of type-specific antigens on the internal proteins. It is also not clear whether cross-reacting antigens are present on all or only on some of the structural proteins. To gain more insight into these problems with FMDV we studied the antigens on intact 14oS FMDV particles of type A subtype IO and type O subtype I and on their virus subunits (I2S) with antisera prepared against the isolated structural proteins. (Barteling, I974) before being grown to appropriate amounts in the same system. The viruses were partly purified and concentrated as previously described (Meloen, I976) except that instead of sucrose gradients, linear CsC1 gradients (1:3o to I :5o g/ml) were used. The purified viruses were diluted twofold with o.I M-NaC1, o'o5 M-tris-HCl, pH 7"6, precipitated with 2 vol. acetone at -2o °C and stored at -2o °C until used (Harris & Brown, 2977) . I2S particles were prepared by acid treatment of purified I4oS as described (Meloen et al. I979) .
Antisera. Antisera against the isolated virus structural proteins were prepared as previously described (Meloen et al. I979) . Briefly, structural proteins of O1 virus were separated on a Io~o polyacrylarnide gel slab using the discontinuous tris-glycine buffer system of Laemmli (I97o) in the presence of o.I ~ SDS. The proteins of A10 virus were separated on the same gel system but in the presence of 8 M-urea. The stained protein bands were cut out, dried under nitrogen gas and suspended in an appropriate volume of 0"05 M-phosphate buffer, pH 7"4, containing 0"2 M-NaCI and o.I ~ SDS. This suspension was left overnight at 50 °C and then emulsified with complete or incomplete Freund's adjuvant. Antisera were raised in duplicate in rabbits, using approx. I5O/2g of virus protein emulsified in complete Freund's adjuvant, followed by similar inocula of antigens in incomplete Freund's adjuvant given 4 and 8 weeks later. Antisera against complete virus (I4oS) and I2S antigen were obtained using three doses of acetylethyleneimine (AEI)-inactivated and acid-degraded I4oS particles in doses of r and IO ¢tg respectively.
Micro-neutralization test (MNT).
Neutralizing activity was determined in a microtitre system using secondary pig kidney cells (De Leeuw et al. I979 ). The sera were tested in twofold dilutions against about IOO TCIDg0. Endpoints, determined according to Reed & Muench 0938) , are expressed as the negative log of the serum dilution endpoint. Sera were considered positive if their titres were /> o'45.
Radio-immunoassay (RIA). Essentially the micromethod described by Crowther (~976) was used. aSS-methionine-labelled virus was incubated with serial dilutions of the specific rabbit antiserum in microtitre plates. After addition of goat anti-rabbit gamma-globulin the precipitates were removed by centrifuging and the radioactivity in the supernatants was counted. The endpoint was taken as the negative log of the serum dilution precipitating 7o~ of the labelled virus. In competition assays, the serum dilution precipitating 3o~ of labelled antigen was first determined. This quantity of serum was then incubated for 26 h at 4 °C with a constant amount of labelled antigen and increasing amounts of the competing homologous or heterologous antigens. Subsequently goat anti-rabbit gamma-globulin was added, the precipitates were removed and the radioactivity in the supernatant counted. The amount of unlabelled ~4oS used for competition was determined spectrophotometrically (Bachrach et al. I964) . The concentrations of the I25 preparations were estimated by the Lowry method (Lowry et al. 195I ) . For a uniform presentation of the results, in Fig. 2 the amounts of competing antigen are expressed as the theoretical amount of antigen (/~g) added to I ml of undiluted serum.
Enzyme-linked immunosorbent assay (ELISA). The method described by Abu Elzein & Crowther (i978) was used, with the exception that the plates were coated with antigen in a o'o5 M-phosphate buffer, pH 7"4, containing o'2 M-NaCI instead of a carbonate buffer, pH 9"6. The antisera were serially diluted in the coated plates. After incubation and washing, the plates were incubated with a I/IOOO dilution of goat anti-rabbit peroxidase conjugate. After washing, the colour was developed with 5-amino-salicylic acid as sub-Cross-reacting antigens of FMD V I o9 strate. The absorbances were read with a Multiscan apparatus (Titertek) at a wave length of 45onm. In competition assays the serum dilution giving 7o% of the maximum absorbance was first determined for every serum. This quantity of serum was then incubated with increasing amounts of homologous or heterologous antigen in the cups. The following steps (washing, incubation with conjugate, etc.) were carried out as described by Abu Elzein & Crowther (I978). For a uniform presentation of the results, in Fig. 3 the amounts of competing antigen are expressed as the theoretical amount of antigen (/zg) added to I ml of undiluted serum.
RESULTS

Separation of the structural polypeptides
Fig . I shows that the structural proteins of virus O1 separated well on SDS-polyacrylamide gel but not on SDS-urea gel. VP 1 is the trypsin-sensitive protein located on the outside of the virion. VP4 is the fastest moving protein, not always visible due to its poor staining. VP2 and VP3 were identified by comparison of the electrophoresis patterns of complete virus and naturally occurring empty particles. The latter contain the much slower migrating VP0 instead of VP 4 and VP2 (Rueckert, I976) . The structural proteins of Aa0 virus separated well on the urea gel. Under these conditions VPa migrated ahead of VP 2 and VPz.
Neutralizing activity
The neutralizing activity of the antisera against different structural proteins of both viruses were determined using the MNT. The results in Table ~ (a) show that anti-VP1 sera have neutralizing activity in contrast to anti-VP2, VP3 and VP4. Anti-~4oS and antiIzS also show neutralizing activity. Antisera against various A10 antigens showed no activity against O1 virus. In contrast, anti-VP1 and anti-~2S type O1 sera showed unexpected cross-reacting neutralizing activity against A10 virus. Because of this, two new anti-VP1 type O1 sera were raised. Again they showed cross-reacting neutralizing activity against A10 virus (data not shown).
Activity measured with RIA and ELISA
Activity against I4oS particles was measured with the RIA while that against I2S was measured with both the RIA and ELISA. Titres obtained in the ELISA were generally higher than those found in the RIA.
Similar results were obtained with the I4oS particles in the RIA as in the MNT (Table i a and b) with the exception that one antiserum against VP1 and one against I4oS particles of type A10 showed heterologous activity. In the RIA and ELISA against I2S type A10 and O1 (Table I c and d ) not only anti-VP1 but also anti-VP2 and anti-VP3 serum of type O1 reacted. The anti-VP1, anti-VP2 and anti-VP3 sera of type A10 did so in the ELISA but hardly at all in the RIA, probably due to the lower sensitivity of the RIA. No reactions were observed with the anti-VP~ sera.
The differences between homologous and heterologous activity obtained with anti-VP1 sera and 14oS preparations were considerable. Much less pronounced was the difference in activity of these sera with homologous and heterologous IzS preparations, while, in general, anti-VP 2 and -VPz sera gave reactions of the same magnitude with I zS preparations of both serotypes (Table I c and d) . Competition experiments To study the differences in avidity between homologous and heterologous reactions, competition assays were done with all sera against both homologous and heterologous I4oS and I2S preparations. The results with I4oS particles are shown in Fig. 2 . For reasons discussed below, competition involving I4oS particles was done only in the RIA. Because the duplicate sera always showed similar patterns, only those with the highest titred serum of each pair are presented. Anti-VP,, anti-I2S and anti-I4oS sera showed considerable cross-reactions with heterologous antigen preparations; however, the reactions with homologous preparations were much stronger than with the heterologous
Anti-14oS Anti-128 ones. This difference was most pronounced for anti-VPa sera. The sera against O1 virus show somewhat more heterologous reactivity than those against A10 virus.
Competition with I28 preparations was done in both ELISA and RIA, the results being virtually the same. Due to the low reactivity of some sera, the RIA could not be applied throughout, in contrast to the ELISA. Therefore, only ELISA results are shown. Because duplicate sera always gave similar results, the results of only one serum are shown. Fig. 3 shows that anti-VP~ serum to A10 virus was completely type-specific. AntiVPz serum reacted with antigens of both homologous and heterologous I2S preparations with the same avidity, while anti-VP 3 serum of type A reacted with heterologous I2S but with lower avidity than with homologous IzS preparations. With anti-I4oS and anti-I2S sera, incomplete cross-reactions were observed.
With anti-VP1, VP2 and VP 3 sera to virus O~, complete cross-reactions were obtained with a decreasing difference between avidities of homologous and heterologous reactions (Fig. 3) in the order VP1, VP3, VP2. Anti-VP2 reacted almost identically with homologous and heterologous I2S. As with A10 virus, anti-i4oS and anti-I2S sera against O1 show incomplete cross-reactions.
DISCUSSION
The immunogenicities of isolated VP2 and VP 3 are less than that of VP1 (Table I) and might be related to their insolubility (Strohmaier et at. I978) . We therefore always kept all the isolated structural proteins in solutions containing o.I ~ SDS. However, this has 3 . Results of the competitive ELISA with I2S virus subumts. In this assay the serum dilution of each serum giving 7o~ of the maximum absorbance was first determined. This quantity of serum was then incubated with increasing amounts of competing homologous (O--O) or heterologous (A---A) IzS. After incubation and washing, goat anti-rabbit peroxidase was added. After further incubation and washing, the colour was developed with the substrate. For reasons of uniformity the amount of competing antigen is expressed as the theoretical amount in pg added to I ml of undiluted serum. (a, e, e, g, i) Type A: anti-VP1 (a), anti-VP~ (c), anti-VP3 (e), anti-I4oS (g) and anti-IzS (i); (b,d,f,h,] 
anti-I4oS (h) and anti-t2S (j). the disadvantage that after injection these preparations not only produced antibodies against the specific antigens but also against the SDS-protein complex (our unpublished results; Lampre et al. I979). These latter antibodies do not interfere in the RIA or ELISA because in these assays SDS is absent. Fig. i shows that the VP1, VP2 and VP 3 of type A10 and VP1 of type O1 preparations used for vaccination were probably homogeneous because these proteins are well separated from each other and are easily cut out of the stained gels in contrast to VP2 and VP 3 of O1 virus, where cross-contamination could not be avoided. Further evidence for the absence of cross-contamination is the presence of neutralizing activity in anti-VP1 I~ 4 R.H. MELOEN AND J. BRIAIRE sera only. Consistent with earlier observations (Meloen et al. ~979) , no anti-VP4 activity was obtained, which perhaps indicates that VP 4 is insoluble even in the presence of SDS. The cross-reacting neutralizing activity in the anti-VP1 sera of O1 virus against A10 virus is rather unexpected. This activity, which is also present in one anti-I2S serum, might be due to some kind of contamination of type O1 virus with type A virus. Contamination of the proteins after they have been eluted from the gels can be ruled out since the heterologous activity is found only in anti-VP 1 and anti-taS serum but not in the others. Contamination of the virus used for the antigenic preparations however remains possible but seems unlikely because (i) the virus used was cloned and received only a few passages in BHK cells; when tested no heterologous complement fixing activity could be found in it (unpublished data); (ii) some of the anti-VP1 type O sera also showed neutralizing activity with type C virus in contrast to anti-I4oS O1 sera (unpublished data), while at the time when these anti-O1 sera were prepared no work was being done with type C virus in our laboratory; (iii) ten passages of the O1 virus on BHK cells in the presence of early convalescent antiserum against O1 did not result in the appearance of virus with heterologous complement-fixing activity (unpublished data); (iv) contaminant virus present in sufficient amounts to induce neutralizing activity in the anti-VP1 preparations would probably have shown up in the anti-i4oS sera but this was not observed. It might be argued that, due to the much larger amounts of VP1 compared with those of I4oS used for vaccination, expression of the contaminant only may have occurred in the anti-VP1 sera. This argument certainly would apply if the immunogenicity of ~4oS and VP 1 is of the same order; however, VP 1 is much less immunogenic than I4oS. Thus it seems unlikely that a contaminant caused these unexpected reactions. Another explanation for the crossreacting neutralizing activity of the anti-VP1 type O1 sera could be that large amounts of VP1 used as immunogen raise antibodies with a broad specificity spectrum compared with those raised with small amounts of I4oS. This possibility cannot be excluded either but also seems unlikely because with the anti-VP1 sera of A10 virus such a broad spectrum is not observed. Not only the neutralizing activities but also the competition experiments with I2S antigen (Fig. 3) show a one-way relationship between O1 and A10. The O1 anti-VP1 sera are more cross-reactive than the A10 anti-VP1 sera. Thus antigens responsible for inducing neutralizing antibodies present on complete virus may differ from those expressed by isolated VP 1 and I2S preparations. It would be of interest if this could be further substantiated, especially since efforts are being made to produce VP1 of FMDV by genetic manipulation for use as a vaccine (Bachrach et al. I978; Anon, I979) .
The cross-reactions observed in RIA and ELISA with I2S particles of both strains (Table I) These cross-reactions were studied further using competition experiments' with the RIA for I4oS particles and both the RIA and ELISA for I2S preparations. The method of choice throughout would have been the ELISA due to its higher sensitivity compared with the RIA. Unfortunately, in our hands, the I4oS antigen, especially of type O, reacted to s.ome extent with anti-VP2 and anti-VP a sera when coated on to the wells of the microtitre plates. These weak but definite reactions were not observed in the RIA (Table I) and perhaps might indicate that the intact virion changes its conformation to some extent when coated on to a surface. This undesired effect could not be prevented by using a carbonate buffer (pH 9"6) for coating, flexible polyvinyl plates nor by fixation of the 
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virus with formaldehyde or glutaraldehyde. Because of this we used the RIA when complete virus was involved. When t2S particles were used both the RIA and ELISA were applied. Except for the lower sensitivity of the RIA no qualitative differences were seen between the tests either in the direct or in the competition assay. This suggests that I2S antigens either free in suspension or adsorbed to a surface behave identically. Competition of I4oS particles of both virus strains and anti-VP1, anti-I2S and antit4oS sera (Fig. z) show cross-reactions with very low avidities, in agreement with the type-specific nature of intact virus. The results of the competition of homologous and heterologous 12S preparations with anti-VPx, -VP2 and -VP3 sera of both O1 and Alo (Fig. 3) show a cross-reaction increasing in the order anti-VP1, anti-VP3, anti-VP2. Anti-VP 2 serum of Ax0 gives identical reactions with IzS preparations of both types. This is less pronounced in the case of anti-VP2 type O1 serum, also due to incomplete specificity of anti-VP2 and anti-VP3 sera. Anti-VP,, type O~ sera showed reproducibly slightly more, cross-reaction than anti-VPz sera. This suggests that if VP 2 and VP3 had been completely separated from each other the differences between both experiments might have been larger, with anti-VP2 of 0, perhaps giving identical reactions with I2S preparations of both types. These results indicate that antigens of IzS preparations exposed by VPx are the most type-specific, those of VP2 are identical while those of VP3 are partly identical. This tendency is in accordance with the results reported by Robson et al. 098o ) who showed that for two A and one O strain the amino acid sequences of VPx and VP3 are highly variable, whereas those of VP2 are relatively more conserved. However, the antigenicity of VP2 and to a lesser extent that of VP3 appears to be more conserved between virus types than their amino acid sequences. One way to explain this is that the variable parts of VP2 and VP 3 are buried inside the I2S particle. Another might be that the changed amino acids do not affect the antigenicity. If this latter explanation is correct and if the conserved antigenicity is related to a conserved role of the protein it follows that certain amino acid sequences may vary, perhaps in a more or less random way, because they are less relevant for the functional role of the polypeptide. A comparable phenomenon has been observed by the HA glycoproteins of influenza viruses (anon, 198o ) . Therefore, our approach might be of additional value to those comparing amino acid sequences, because it reveals similarities not observed otherwise.
As was to be expected, large differences occur when anti-14oS sera are tested in competition assays with homologous and heterologous I2S preparations (Fig. 3) . It is surprising, however, that the anti-IzS sera against O1 in particular are not more cross-reactive, because ~2S exposes three proteins which, when isolated, are able to raise antibodies that are considerably more cross-reactive than anti-izS antibodies. A tentative explanation might be the immunogenic dominance of the type-specific antigens (mostly on VP0 of I zS particles over the cross-reacting antigens (on VP2 and VP3) which is perhaps related to the observed poorer immunogenicity of VP~ and VP3.
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